CIK 0001668243 · Non-accelerated filer<br>Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 9 770 7601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Chief Financial Officer | Sale | −2,202 | $36.69 | $81K | 4,561 |
| 2026-09-08 | Schoenberg Mark Chief Medical Officer | Sale | −871 | $42.92 | $37K | 59,882 |
| 2026-09-08 | Smith Jason Drew General Counsel | Sale | −1,519 | $42.54 | $65K | 53,141 |
| 2026-08-20 | Schoenberg Mark Chief Medical Officer | Sale | −60,677 | $47.05 | $2.9M | 59,086 |
| 2026-07-09 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $40.00 | $400K | 119,763 |
| 2026-06-22 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $35.01 | $350K | 129,763 |
| 2026-06-08 | Schoenberg Mark Chief Medical Officer | Sale | −5,222 | $27.30 | $143K | 139,763 |
| 2026-05-08 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $30.00 | $300K | 134,985 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −2,654 | $19.69 | $52K | 52,934 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −1,608 | $19.69 | $32K | 51,326 |
| 2026-02-03 | Smith Jason Drew General Counsel | Sale | −3,217 | $19.69 | $63K | 55,588 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −1,844 | $19.69 | $36K | 150,514 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −1,843 | $19.69 | $36K | 148,671 |
| 2026-02-03 | Schoenberg Mark Chief Medical Officer | Sale | −3,686 | $19.69 | $73K | 144,985 |
| 2025-11-19 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $25.00 | $250K | 139,025 |
| 2025-10-08 | Degnan Chris Chief Financial Officer | Sale | −2,203 | $16.85 | $37K | 2,280 |
| 2025-09-08 | Schoenberg Mark Chief Medical Officer | Sale | −871 | $19.11 | $17K | 149,025 |
| 2025-09-08 | Smith Jason Drew General Counsel | Sale | −1,520 | $19.11 | $29K | 43,305 |
| 2025-08-11 | Schoenberg Mark Chief Medical Officer | Sale | −10,000 | $17.69 | $177K | 148,229 |
| 2025-07-28 | Smith Jason Drew General Counsel | Sale | −7,522 | $19.14 | $144K | 41,492 |
Page 1 of 3 · 53 trades